SCHEMBL4979429

SCHEMBL4979429

O=C(CO)n1cccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18787369 0.79 FBP1 (0.33)
SCHEMBL23611391 0.79 FBP1 (0.33)
SCHEMBL5065336 0.74
SCHEMBL10676122 0.74
SCHEMBL28801587 0.74
SCHEMBL4376441 0.74
SCHEMBL11572551 0.74
SCHEMBL10784064 0.74
SCHEMBL9853841 0.74
SCHEMBL27582678 0.74 CAMK2A (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106459044-A Tank-binding kinase inhibitor compounds 吉利德科学公司 2017-02-22 CN disclosed
US-9220827-B2 Apparatus for extracorporeal blood treatment B. BRAUN AVITUM AG (DE) 2015-12-29 US disclosed
US-20130237896-A1 APPARATUS FOR EXTRACORPOREAL BLOOD TREATMENT B. BRAUN AVITUM AG (DE) 2013-09-12 US disclosed
WO-2008016643-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INCORPORATED (US) 2008-02-07 WO disclosed
EP-1257272-A4 THIAZOLIUM COMPOUNDS AND TREATMENTS OF DISORDERS ASSOCIATED WITH PROTEIN AGING ALTEON INC (US) 2004-12-15 EP disclosed
EP-1248615-A4 THIAZOLE, IMIDAZOLE AND OXAZOLE COMPOUNDS AND TREATMENTS OF DISORDERS ASSOCIATED WITH PROTEIN AGING ALTEON INC (US) 2004-08-04 EP disclosed
EP-1303501-A4 CYANOMETHYL SUBSTITUTED THIAZOLIUMS AND IMIDAZOLIUMS AND TREATMENTS OF DISORDERS ASSOCIATED WITH PROTEIN AGING ALTEON INC (US) 2004-03-03 EP disclosed
WO-2003102007-A1 PROCESS FOR SYNTHESISING C-GLYCOSIDES THE AUSTRALIAN NATIONAL UNIVERSITY (AU) 2003-12-11 WO disclosed
EP-1303501-A1 CYANOMETHYL SUBSTITUTED THIAZOLIUMS AND IMIDAZOLIUMS AND TREATMENTS OF DISORDERS ASSOCIATED WITH PROTEIN AGING Alteon, Inc. (US) 2003-04-23 EP disclosed
EP-1257272-A1 THIAZOLIUM COMPOUNDS AND TREATMENTS OF DISORDERS ASSOCIATED WITH PROTEIN AGING Alteon, Inc. (US) 2002-11-20 EP disclosed
WO-2001052847-A1 THIAZOLE, IMIDAZOLE AND OXAZOLE COMPOUNDS AND TREATMENTS OF DISORDERS ASSOCIATED WITH PROTEIN AGING ALTEON, INC. (US) 2001-07-26 WO disclosed
EP-1104412-A1 TACE INHIBITORS Pfizer Products Inc. (US) 2001-06-06 EP disclosed
WO-2000009492-A1 TACE INHIBITORS PFIZER PRODUCTS INC. (US) 2000-02-24 WO disclosed
WO-1996040663-A1 DI- AND TRI-AMINOGUANIDINES AND THEIR USE TO INHIBIT THE ADVANCED GLYCOSYLATION OF PROTEINS ALTEON INC. (US) 1996-12-19 WO disclosed
EP-0566698-A1 AMINO-SUBSTITUTED PYRIMIDINES, DERIVATIVES AND METHODS OF USE THEREFOR THE ROCKEFELLER UNIVERSITY (US) 1993-10-27 EP disclosed
WO-1993013775-A1 DIAMINOPYRIDINE COMPOUNDS FOR THE INHIBITION OF PROTEIN GLYCOSYLATION THE ROCKEFELLER UNIVERSITY (US) 1993-07-22 WO disclosed
WO-1992019236-A1 2-ALKYLIDENE-AMINOGUANIDINES FOR INHIBITING ADVANCED NONENZYMATICGLYCOSYLATION OF PROTEINS THE ROCKEFELLER UNIVERSITY (US) 1992-11-12 WO disclosed
WO-1992014704-A1 2-SUBSTITUTED-2-IMIDAZOLINES THE ROCKEFELLER UNIVERSITY (US) 1992-09-03 WO disclosed
WO-1992011853-A1 AMINO-SUBSTITUTED PYRIMIDINES, DERIVATIVES AND METHODS OF USE THEREFOR THE ROCKEFELLER UNIVERSITY (US) 1992-07-23 WO disclosed
WO-1992007560-A1 BIGUANIDES AND DERIVATIVES THEREOF AS INHIBITORS OF ADVANCED GLYCOSYLATION OF A TARGET PROTEIN THE ROCKEFELLER UNIVERSITY (US) 1992-05-14 WO disclosed